CLEARONE INC (CLRO) — Institutional Holders, Q2 2026

10 institutional investment managers reported a CLRO position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $365.1K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

CLRO in Q2 2026: what funds did

Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

1

Added to

1

Trimmed

2

Sold out

0

Biggest buyers

  1. Tower Research Capital (TRC)Added · +522 sh+$1.7K
  2. Caitong International Asset Management , LtdNew · +1 sh+$3.00

Biggest sellers

  1. Shay CapitalTrimmed · -10,114 sh-$33.7K
  2. GEODE CAPITAL MANAGEMENTTrimmed · -2,991 sh-$10.0K

CLRO 13F holders ranked 1–10 of 10

Institutional investors reporting a position in CLEARONE INC on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
Shay Capital#1 · 45,486 sh$151.5K-18.2%
T3 Companies#2 · 30,000 sh$99.9K0.0%
ALBION FINANCIAL GROUP#3 · 14,465 sh$48.2K0.0%
GEODE CAPITAL MANAGEMENT#4 · 10,834 sh$36.1K-21.6%
VANGUARD CAPITAL MANAGEMENT#5 · 5,258 sh$17.5K0.0%
VANGUARD FIDUCIARY#6 · 2,395 sh$8.0K0.0%
Tower Research Capital (TRC)#7 · 1,161 sh$3.9K+81.7%
FINANCIAL CONSULATE#8 · 15 sh$50.000.0%
SBI Securities , Ltd.#9 · 10 sh$33.000.0%
Caitong International Asset Management , Ltd#10 · 1 sh$3.00New

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.